River Renal
Novel therapies for orphan renal diseases
New York, United States · $10.0M raised
- Headquarters
- New York
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $10.0M
- Last Round
- $10.0M Seed
- Rounds
- 1
About
River Renal is a clinical-stage biopharmaceutical company developing novel therapies for orphan renal diseases with high unmet medical needs. Backed by Bain Capital Life Sciences and Pureos Bioventures, the company focuses on discovery and development of first-in-class drug candidates targeting rare kidney disorders where existing treatment options remain limited. River Renal has received investment from multiple healthcare-focused venture capital firms including HBM Healthcare Investments and SR One, reflecting strong institutional confidence in its pipeline approach. The company is headquartered in New York and operates as a lean clinical-stage organization focused on translating innovative science into treatments for patients with serious kidney conditions.
Summary
River Renal is a Biotech company based in New York, United States. It has raised $10.0M in total across 1 round. Investors include Roche, Bain Capital Life Sciences and HBM Partners.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/river-renal"><img src="https://indexed.vc/api/badge/company/river-renal" alt="River Renal on Indexed.vc" width="260" height="76" /></a>